...
首页> 外文期刊>Life sciences >Combination therapy with semaglutide and rosiglitazone as a synergistic treatment for diabetic retinopathy in rodent animals
【24h】

Combination therapy with semaglutide and rosiglitazone as a synergistic treatment for diabetic retinopathy in rodent animals

机译:用Semlutide和Rosiglitazone的组合疗法作为啮齿动物动物患有糖尿病视网膜病变的协同治疗

获取原文
获取原文并翻译 | 示例

摘要

Objective: To investigate the protective efficacies and potent mechanisms of combination therapy with semaglutide and rosiglitazone (RSG) on the high-glucose incubated human ARPE-19 cells and diabetic retinopathy (DR) model rats.
机译:目的:探讨塞马鲁肽和罗格列酮(RSG)联合治疗对高糖培养的人ARPE-19细胞和糖尿病视网膜病变(DR)模型大鼠的保护作用及其机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号